Cardiovascular News

2 weeks ago | cardiovascularnews.com | Eva Malpass

A STRIKE-PE interim analysis of clinical outcomes of acute pulmonary embolism (PE) patients with or without syncope—an indicator of compromised cardiac output and so increased short-term mortality—has found that patients with syncope who had a higher right/left ventricle (RV/LV) ratio at baseline were restored to a condition similar to patients without syncope following treatment with the Lightning Flash (Penumbra) computer-assisted vacuum thrombectomy (CAVT) device.

1 month ago | cardiovascularnews.com | Jocelyn Hudson

Evident Vascular has announced the successful closing of its Series B financing with new investors Shangbay Capital and two undisclosed multinational strategics joining founding investor Vensana Capital. A press release details that the funding will accelerate development of the company’s advanced intravascular ultrasound (IVUS) technology designed to enhance vascular imaging and patient outcomes and support 510(k) US Food and Drug Administration (FDA) clearance ahead of US market launch.

Jan 23, 2025 | cardiovascularnews.com | Eva Malpass

FastWave Medical has announced the issuance of its seventh utility patent by the US Patent and Trademark Office (USPTO). This patent covers FastWave’s laser intravascular lithotripsy (IVL) technology, specifically engineered to address calcified arteries. “Calcified arteries remain one of the most difficult conditions to treat in our field,” said interventional cardiologist Amir Kaki (Henry Ford St. John’s Hospital, Detroit, USA).

Jan 13, 2025 | cardiovascularnews.com | Eva Malpass

Piccolo Medical has announced an exclusive distribution agreement with Spectrum Vascular. Spectrum Vascular offers a portfolio of venous catheters that leverage the Spectrum antimicrobial and BioFlo thrombus reduction technologies. Under the partnership, Spectrum Vascular will serve as the sole distributor of the Piccolo Medical catheter navigation and tip confirmation devices, including the ECGuide and SmartPICC product lines.

Oct 29, 2024 | cardiovascularnews.com | Eva Malpass

Findings from the first international randomised controlled trial (RCT) to compare patient outcomes following treatment with large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT) for intermediate-risk pulmonary embolism (PE) found that LBMT is superior with respect to the hierarchically-tested aggregated outcome of all-cause mortality, intracranial haemorrhage, major bleeding, clinical deterioration and/or escalation to bailout therapy, and postprocedural...